Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planNo plan disclosedOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 3 of the 13 calendar months from Oct 2025 to Oct 2026: Dec 2025, Mar 2026 and May 2026.
- Largest single sale: $3.3M (115,468 shares) of Teva Pharmaceutical Industries Ltd on Dec 9, 2025. Filing
- Last sale before this period: Mar 5, 2025.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Teva Pharmaceutical Industries Ltd (TEVA) | EVP, Europe Commercial | Jan 2, 2018 | May 7, 2026 |
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- May 5, 2026, Teva Pharmaceutical Industries Ltd: sold 30,000 shares for $1.1M, no plan disclosed. 1 filing: 1
- Mar 5, 2026, Teva Pharmaceutical Industries Ltd: sold 17,295 shares for $548K, under a disclosed plan; 17,295 shares vested. 1 filing: 1
- Mar 4, 2026, Teva Pharmaceutical Industries Ltd: sold 91,345 shares for $3.0M, under a disclosed plan; 53,973 shares vested. 1 filing: 1
- Mar 3, 2026, Teva Pharmaceutical Industries Ltd: sold 128,985 shares for $4.2M, under a disclosed plan; 203,728 shares vested. 1 filing: 1
- Dec 9, 2025, Teva Pharmaceutical Industries Ltd: sold 115,468 shares for $3.3M, no plan disclosed; 115,468 shares acquired by exercising options. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.